Position in BSX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,368,389
-$647,596 QoQ
Shares Held
21,807
+3.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Derivatives in BSX
reported options exposure · as of Mar 31, 2026CallValue
$50,200
CallShares
800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026Lebenthal Global Advisors, LLC holds $933,201 across 1 Medical Devices name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DXCM |
Dexcom Inc
|
13,856 | $933,201 |
All Filings in BSX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,368,389 | 21,807 | Shares | Defined | 2026-05-14 | |
| 2026-03-31 | $50,200 | 800 | Call | Sole | 2026-05-14 | |
| 2025-12-31 | $2,015,985 | 21,143 | Shares | Defined | 2026-01-28 | |
| 2025-12-31 | $19,070 | 200 | Call | Sole | 2026-01-28 | |
| 2025-09-30 | $1,897,439 | 19,435 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $2,010,607 | 18,719 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,881,109 | 18,647 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,825,254 | 20,435 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $1,716,475 | 20,483 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,450,713 | 18,838 | Shares | Defined | 2024-07-24 | |
| 2024-03-31 | $1,270,489 | 18,550 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $976,757 | 16,896 | Shares | Sole | 2024-02-07 | |
| No filing history on record for this holder in this stock. | ||||||